![]() 嚥下障害ルソリア治療-世界市場シェアとランキング、全体売上高と需要予測 2025-2031Dysphagia Lusoria Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 嚥下障害ルソリア治療の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されています。 ルソリア嚥下障害は... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー嚥下障害ルソリア治療の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されています。ルソリア嚥下障害は、食道を圧迫する右鎖骨下動脈の異常または異常の存在による嚥下困難(嚥下障害)を特徴とする病状である。右鎖骨下動脈は通常、大動脈から特定の位置で分岐しているが、嚥下障害の場合、別の経路をとり、食道を圧迫し閉塞させる。ルソリア嚥下障害の治療法は、食道の圧迫を緩和し、嚥下機能を改善することを目的とする。 世界の医薬品市場は、2022年には1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には化学医薬品と生物学的製剤がある。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 本レポートは、ルソリア嚥下障害治療薬の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別のルソリア嚥下障害治療薬の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 ルソリア嚥下障害治療剤の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データを売上高(百万ドル)で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、嚥下障害ルソリア治療に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 ブリストル・マイヤーズ スクイブ社 ファイザー アストラゼネカ ペリゴ社 ジョンソン・エンド・ジョンソン テバ・ファーマシューティカルズ メドトロニック トーラックスメディカル グラクソ・スミスクライン Plc. タイプ別セグメント 手術治療 医療治療 用途別セグメント 病院 診療所 小売薬局 その他 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章: レポートのスコープ、世界の総市場規模を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章:嚥下障害ルソリア治療企業の競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模や発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第5章:地域レベルでの嚥下障害ルソリア治療の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場スペース、市場規模を紹介しています。 第6章 ルソリア嚥下障害治療の国別収益各国/地域のタイプ別、用途別のシグメイトデータを提供します。 第7章:主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Dysphagia Lusoria Treatment Product Introduction 1.2 Global Dysphagia Lusoria Treatment Market Size Forecast (2020-2031) 1.3 Dysphagia Lusoria Treatment Market Trends & Drivers 1.3.1 Dysphagia Lusoria Treatment Industry Trends 1.3.2 Dysphagia Lusoria Treatment Market Drivers & Opportunity 1.3.3 Dysphagia Lusoria Treatment Market Challenges 1.3.4 Dysphagia Lusoria Treatment Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Dysphagia Lusoria Treatment Players Revenue Ranking (2024) 2.2 Global Dysphagia Lusoria Treatment Revenue by Company (2020-2025) 2.3 Key Companies Dysphagia Lusoria Treatment Manufacturing Base Distribution and Headquarters 2.4 Key Companies Dysphagia Lusoria Treatment Product Offered 2.5 Key Companies Time to Begin Mass Production of Dysphagia Lusoria Treatment 2.6 Dysphagia Lusoria Treatment Market Competitive Analysis 2.6.1 Dysphagia Lusoria Treatment Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Dysphagia Lusoria Treatment Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dysphagia Lusoria Treatment as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Operation Treatment 3.1.2 Medical Treatement 3.2 Global Dysphagia Lusoria Treatment Sales Value by Type 3.2.1 Global Dysphagia Lusoria Treatment Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Dysphagia Lusoria Treatment Sales Value, by Type (2020-2031) 3.2.3 Global Dysphagia Lusoria Treatment Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Retail Pharmacy 4.1.4 Others 4.2 Global Dysphagia Lusoria Treatment Sales Value by Application 4.2.1 Global Dysphagia Lusoria Treatment Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Dysphagia Lusoria Treatment Sales Value, by Application (2020-2031) 4.2.3 Global Dysphagia Lusoria Treatment Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Dysphagia Lusoria Treatment Sales Value by Region 5.1.1 Global Dysphagia Lusoria Treatment Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Dysphagia Lusoria Treatment Sales Value by Region (2020-2025) 5.1.3 Global Dysphagia Lusoria Treatment Sales Value by Region (2026-2031) 5.1.4 Global Dysphagia Lusoria Treatment Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.2.2 North America Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.3.2 Europe Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.4.2 Asia Pacific Dysphagia Lusoria Treatment Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.5.2 South America Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.6.2 Middle East & Africa Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Dysphagia Lusoria Treatment Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.3 United States 6.3.1 United States Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.3.2 United States Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.4.2 Europe Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.5.2 China Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.5.3 China Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.6.2 Japan Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.7.2 South Korea Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.8.2 Southeast Asia Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.9.2 India Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.9.3 India Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Bristol-Myers Squibb Company 7.1.1 Bristol-Myers Squibb Company Profile 7.1.2 Bristol-Myers Squibb Company Main Business 7.1.3 Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Products, Services and Solutions 7.1.4 Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.1.5 Bristol-Myers Squibb Company Recent Developments 7.2 Pfizer 7.2.1 Pfizer Profile 7.2.2 Pfizer Main Business 7.2.3 Pfizer Dysphagia Lusoria Treatment Products, Services and Solutions 7.2.4 Pfizer Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.2.5 Pfizer Recent Developments 7.3 AstraZeneca plc 7.3.1 AstraZeneca plc Profile 7.3.2 AstraZeneca plc Main Business 7.3.3 AstraZeneca plc Dysphagia Lusoria Treatment Products, Services and Solutions 7.3.4 AstraZeneca plc Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.3.5 AstraZeneca plc Recent Developments 7.4 Perrigo Company plc 7.4.1 Perrigo Company plc Profile 7.4.2 Perrigo Company plc Main Business 7.4.3 Perrigo Company plc Dysphagia Lusoria Treatment Products, Services and Solutions 7.4.4 Perrigo Company plc Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.4.5 Perrigo Company plc Recent Developments 7.5 Johnson & Johnson 7.5.1 Johnson & Johnson Profile 7.5.2 Johnson & Johnson Main Business 7.5.3 Johnson & Johnson Dysphagia Lusoria Treatment Products, Services and Solutions 7.5.4 Johnson & Johnson Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.5.5 Johnson & Johnson Recent Developments 7.6 Teva Pharmaceuticals 7.6.1 Teva Pharmaceuticals Profile 7.6.2 Teva Pharmaceuticals Main Business 7.6.3 Teva Pharmaceuticals Dysphagia Lusoria Treatment Products, Services and Solutions 7.6.4 Teva Pharmaceuticals Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.6.5 Teva Pharmaceuticals Recent Developments 7.7 Medtronic plc 7.7.1 Medtronic plc Profile 7.7.2 Medtronic plc Main Business 7.7.3 Medtronic plc Dysphagia Lusoria Treatment Products, Services and Solutions 7.7.4 Medtronic plc Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.7.5 Medtronic plc Recent Developments 7.8 Torax Medical 7.8.1 Torax Medical Profile 7.8.2 Torax Medical Main Business 7.8.3 Torax Medical Dysphagia Lusoria Treatment Products, Services and Solutions 7.8.4 Torax Medical Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.8.5 Torax Medical Recent Developments 7.9 GlaxoSmithKline Plc. 7.9.1 GlaxoSmithKline Plc. Profile 7.9.2 GlaxoSmithKline Plc. Main Business 7.9.3 GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Products, Services and Solutions 7.9.4 GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.9.5 GlaxoSmithKline Plc. Recent Developments 8 Industry Chain Analysis 8.1 Dysphagia Lusoria Treatment Industrial Chain 8.2 Dysphagia Lusoria Treatment Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Dysphagia Lusoria Treatment Sales Model 8.5.2 Sales Channel 8.5.3 Dysphagia Lusoria Treatment Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Dysphagia Lusoria Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Dysphagia Lusoria Treatment Product Introduction 1.2 Global Dysphagia Lusoria Treatment Market Size Forecast (2020-2031) 1.3 Dysphagia Lusoria Treatment Market Trends & Drivers 1.3.1 Dysphagia Lusoria Treatment Industry Trends 1.3.2 Dysphagia Lusoria Treatment Market Drivers & Opportunity 1.3.3 Dysphagia Lusoria Treatment Market Challenges 1.3.4 Dysphagia Lusoria Treatment Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Dysphagia Lusoria Treatment Players Revenue Ranking (2024) 2.2 Global Dysphagia Lusoria Treatment Revenue by Company (2020-2025) 2.3 Key Companies Dysphagia Lusoria Treatment Manufacturing Base Distribution and Headquarters 2.4 Key Companies Dysphagia Lusoria Treatment Product Offered 2.5 Key Companies Time to Begin Mass Production of Dysphagia Lusoria Treatment 2.6 Dysphagia Lusoria Treatment Market Competitive Analysis 2.6.1 Dysphagia Lusoria Treatment Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Dysphagia Lusoria Treatment Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dysphagia Lusoria Treatment as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Operation Treatment 3.1.2 Medical Treatement 3.2 Global Dysphagia Lusoria Treatment Sales Value by Type 3.2.1 Global Dysphagia Lusoria Treatment Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Dysphagia Lusoria Treatment Sales Value, by Type (2020-2031) 3.2.3 Global Dysphagia Lusoria Treatment Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Retail Pharmacy 4.1.4 Others 4.2 Global Dysphagia Lusoria Treatment Sales Value by Application 4.2.1 Global Dysphagia Lusoria Treatment Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Dysphagia Lusoria Treatment Sales Value, by Application (2020-2031) 4.2.3 Global Dysphagia Lusoria Treatment Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Dysphagia Lusoria Treatment Sales Value by Region 5.1.1 Global Dysphagia Lusoria Treatment Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Dysphagia Lusoria Treatment Sales Value by Region (2020-2025) 5.1.3 Global Dysphagia Lusoria Treatment Sales Value by Region (2026-2031) 5.1.4 Global Dysphagia Lusoria Treatment Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.2.2 North America Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.3.2 Europe Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.4.2 Asia Pacific Dysphagia Lusoria Treatment Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.5.2 South America Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Dysphagia Lusoria Treatment Sales Value, 2020-2031 5.6.2 Middle East & Africa Dysphagia Lusoria Treatment Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Dysphagia Lusoria Treatment Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.3 United States 6.3.1 United States Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.3.2 United States Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.4.2 Europe Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.5.2 China Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.5.3 China Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.6.2 Japan Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.7.2 South Korea Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.8.2 Southeast Asia Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Dysphagia Lusoria Treatment Sales Value, 2020-2031 6.9.2 India Dysphagia Lusoria Treatment Sales Value by Type (%), 2024 VS 2031 6.9.3 India Dysphagia Lusoria Treatment Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Bristol-Myers Squibb Company 7.1.1 Bristol-Myers Squibb Company Profile 7.1.2 Bristol-Myers Squibb Company Main Business 7.1.3 Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Products, Services and Solutions 7.1.4 Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.1.5 Bristol-Myers Squibb Company Recent Developments 7.2 Pfizer 7.2.1 Pfizer Profile 7.2.2 Pfizer Main Business 7.2.3 Pfizer Dysphagia Lusoria Treatment Products, Services and Solutions 7.2.4 Pfizer Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.2.5 Pfizer Recent Developments 7.3 AstraZeneca plc 7.3.1 AstraZeneca plc Profile 7.3.2 AstraZeneca plc Main Business 7.3.3 AstraZeneca plc Dysphagia Lusoria Treatment Products, Services and Solutions 7.3.4 AstraZeneca plc Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.3.5 AstraZeneca plc Recent Developments 7.4 Perrigo Company plc 7.4.1 Perrigo Company plc Profile 7.4.2 Perrigo Company plc Main Business 7.4.3 Perrigo Company plc Dysphagia Lusoria Treatment Products, Services and Solutions 7.4.4 Perrigo Company plc Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.4.5 Perrigo Company plc Recent Developments 7.5 Johnson & Johnson 7.5.1 Johnson & Johnson Profile 7.5.2 Johnson & Johnson Main Business 7.5.3 Johnson & Johnson Dysphagia Lusoria Treatment Products, Services and Solutions 7.5.4 Johnson & Johnson Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.5.5 Johnson & Johnson Recent Developments 7.6 Teva Pharmaceuticals 7.6.1 Teva Pharmaceuticals Profile 7.6.2 Teva Pharmaceuticals Main Business 7.6.3 Teva Pharmaceuticals Dysphagia Lusoria Treatment Products, Services and Solutions 7.6.4 Teva Pharmaceuticals Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.6.5 Teva Pharmaceuticals Recent Developments 7.7 Medtronic plc 7.7.1 Medtronic plc Profile 7.7.2 Medtronic plc Main Business 7.7.3 Medtronic plc Dysphagia Lusoria Treatment Products, Services and Solutions 7.7.4 Medtronic plc Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.7.5 Medtronic plc Recent Developments 7.8 Torax Medical 7.8.1 Torax Medical Profile 7.8.2 Torax Medical Main Business 7.8.3 Torax Medical Dysphagia Lusoria Treatment Products, Services and Solutions 7.8.4 Torax Medical Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.8.5 Torax Medical Recent Developments 7.9 GlaxoSmithKline Plc. 7.9.1 GlaxoSmithKline Plc. Profile 7.9.2 GlaxoSmithKline Plc. Main Business 7.9.3 GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Products, Services and Solutions 7.9.4 GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Revenue (US$ Million) & (2020-2025) 7.9.5 GlaxoSmithKline Plc. Recent Developments 8 Industry Chain Analysis 8.1 Dysphagia Lusoria Treatment Industrial Chain 8.2 Dysphagia Lusoria Treatment Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Dysphagia Lusoria Treatment Sales Model 8.5.2 Sales Channel 8.5.3 Dysphagia Lusoria Treatment Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD(demand)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|